New Delhi: Torrent Pharmaceuticals Ltd. reported a 56.45 percent increase in consolidated net profit to Rs 449 crore for the March quarter, driven by higher revenue. In the same period of the previous fiscal, the company had posted a consolidated net profit of Rs 287 crore, according to a regulatory filing by Torrent Pharmaceuticals on Friday.
Consolidated revenue from operations in the fourth quarter of FY24 reached Rs 2,745 crore, up from Rs 2,491 crore in the year-ago period. Indian revenue was Rs 1,380 crore, a 10 percent increase, while revenue from Brazil was Rs 372 crore, marking a 17 percent growth. Revenue from Germany stood at Rs 280 crore, an 11 percent rise in the quarter.
However, US business revenue fell by 6 percent to Rs 262 crore. Total expenses for the quarter increased to Rs 2,145 crore, compared to Rs 2,067 crore in the same period a year ago. For the fiscal year ended March 31, 2024, consolidated net profit rose to Rs 1,656 crore from Rs 1,245 crore in the previous year. Consolidated revenue from operations for FY24 was Rs 10,728 crore, compared to Rs 9,620 crore in FY23.
You may like also
neet mds counselling 2024 reduced percentile special vacancy round announced
